Fasoracetam vs Phenylpiracetam for focus
Short answer: For focus, more users report improvement with Fasoracetam — 98% of 59 reports, versus 93% of 346 for Phenylpiracetam.
Fasoracetam has 1 meta-analyses and 0 randomized trials on PubMed; Phenylpiracetam has 0 and 0.
Based on 279 reports about Fasoracetam and 959 about Phenylpiracetam. Not medical advice.
| Fasoracetam Supplement | Phenylpiracetam Supplement | |
|---|---|---|
| Users say it helped | 83%helped112 reports · high confidence | 63%helped499 reports · high confidence |
| Verdict | Mostly positive | Mostly positive |
| Research | BResearch: Moderate | DResearch: None |
| Meta-analyses / RCTs | 1 / 0 | 0 / 0 |
| Mainly used for | ||
| Focus % reporting improvement | 98% (59) | 93% (346) |
| Energy % reporting improvement | 100% (10) | 94% (199) |
| Mood % reporting improvement | 100% (18) | 87% (100) |
| Anxiety % reporting improvement | 94% (49) | 71% (41) |
| Performance % reporting improvement | — | 100% (47) |
| Common side effects | drowsiness, headache, tolerance, anorgasmia | tolerance, insomnia, headache, jitteriness |
| Typical dose reported | 50 mg | 100 mg / 100mg 5 days a week with 2 days off or 200mg once a week |
However, they may offer comparable or better tolerability. Additionally, agents acting on etiopathophysiological targets disrupted in specific subgroups of patients with ADHD will move forward the pharmacotherapy of ADHD from a 'one size fits all' to a 'precision medicine' approach.
Expert Rev Neurother, 2019 ↗“the tingle of disassociation and anxiety that lurks at the back of my mind at all times was gone, it felt as though i had finally been released from a prison cell.”
“I took 100 mgs of phenylpiracetam. I was laughing with friends, I felt GOOD.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate